Understanding contrast media

Journal of Infusion Nursing

Volumn 27, Issue 5, 2004, Pages 302-312

  Costa, Nancy ^a,b  

^a INDIANA UNIVERSITY HEALTH   (United States)

^b METHODIST HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; ANTITHROMBIN III; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DIATRIZOATE; DICOUMAROL; DILTIAZEM; GLUCAGON; HEPARIN; IODAMIDE; IODINATED CONTRAST MEDIUM; IODIXANOL; IOHEXOL; IOPAMIDOL; IOPROMIDE; IOTALAMIC ACID; IOVERSOL; IOXAGLIC ACID; METFORMIN; METOPROLOL; METRIZAMIDE; NIFEDIPINE; PROPRANOLOL DERIVATIVE; STEROID; TIMOLOL; UNINDEXED DRUG; VERAPAMIL; WARFARIN;

AIRWAY OBSTRUCTION; ANAPHYLAXIS; ANXIETY DISORDER; ASTHMA; BLOOD CLOTTING DISORDER; BRADYCARDIA; BRONCHOSPASM; CARDIOPULMONARY ARREST; CAUSE OF DEATH; CHEMICAL STRUCTURE; CHEMOTAXIS; CHILL; CONCENTRATION (PARAMETERS); CONVULSION; CYANOSIS; DIABETES MELLITUS; DIZZINESS; DRUG ERUPTION; DRUG FEVER; DRUG HYPERSENSITIVITY; DYSPNEA; ELECTROLYTE BALANCE; FACE EDEMA; FLU LIKE SYNDROME; FLUSHING; HEADACHE; HEART FAILURE; HEAT; HUMAN; HYPERTENSION; HYPOTENSION; INCIDENCE; INFECTION; INJECTION PAIN; ISOTOPE LABELING; KIDNEY DISEASE; KIDNEY FAILURE; LACTIC ACIDOSIS; LARYNX EDEMA; LIVER DYSFUNCTION; MYDRIASIS; NAUSEA; NURSE; OSMOLALITY; PALLOR; PARALYSIS; PATIENT SELECTION; PREMEDICATION; PRIORITY JOURNAL; RADIODIAGNOSIS; REVIEW; RISK ASSESSMENT; SHOCK; SIDE EFFECT; SKIN MANIFESTATION; SWEATING; TACHYCARDIA; TASTE DISORDER; THORAX PAIN; TREATMENT WITHDRAWAL; UNITED STATES; URTICARIA; VISCOSITY; VOMITING; WHEEZING;

ANAPHYLAXIS; CONTRAST MEDIA; DIAGNOSTIC IMAGING; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; HUMANS; IODINE COMPOUNDS; KIDNEY DISEASES; MOLECULAR STRUCTURE; NURSE'S ROLE; OSMOLAR CONCENTRATION; RISK FACTORS; VISCOSITY;

EID: 4544355943     PISSN: 15331458     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129804-200409000-00004     Document Type: Review

References (64)

1. Osborne ED, Sutherland CG, Scholl AJ, Rowntree LD. Roentgenography of the urinary tract during excretion of sodium iodine. JAMA. 1923;80:368-373.
2. Hash RB. Intravascular radiographic contrast media: issues for family physicians. J Am Board Fam Pract. 1999;12(1):32-42.
3. American College of Radiology Committee on Drugs and Contrast Media and General and Pediatric Committee. ACR Book of Standards. Reston, VA: American College of Radiology; 2001.
4. American College of Radiology Committee on Drugs and Contrast Media. Manual on Contrast Media. 4th ed. Reston, Va: American College of Radiology; 1998.
5. McClellan V, Stolberg H. Intravascular contrast media: ionic versus nonionic: current status. Radiol Clin North Am. 1991;29(3):437-454.
6. Maddox TG. Adverse reactions to contrast material: recognition, prevention, and treatment. Am Fam Physician. 2002;66(7):1229-1234.
7. American College of Cardiology Cardiovascular Imaging Committee in collaboration with the Cardiac Catheterization Committee. Position statement: use of nonionic or low-osmolar contrast agents in cardiovascular procedures. J Am Coll Cardiol. 1993;21:269-273.
8. Morris TW. X-ray contrast media: where are we now, and where are we going? Radiology. 1993;188(1):11-16.
9. Katzberg RW. The Contrast Manual. Baltimore, Md: Williams & Wilkins; 1992.
10. Almen T. The etiology of contrast medium reactions. Invest Radiol. 1994;29(Suppl 1):S37-S45.
11. Schraeder R. Contrast media selection in interventional cardiology. J Clin Basic Cardiol. 2001;4:245-248.
12. Hankins J, Lonsway RAW, Hedrick C, Perdue MB. Infusion Therapy in Clinical Practice. 2nd ed. Philadelphia: WB Saunders; 2001.
13. Guyton AC. Basic Human Physiology: Normal Function and Mechanisms of Disease. 2nd ed. Philadelphia, Pa: WB Saunders; 1977.
14. Barrett BJ, Parfrey PS, Mc Donald JR, Hefferton DM, Reddy ER, McManamon PJ. Nonionic low-osmolality versus ionic high-osmolality contrast material for intravenous use in patients perceived to be at high risk: randomized trial. Radiology. 1992;183:105-110.
15. Cochran ST, Bomyea K, Sayre JW. Trends in adverse events after IV administration of contrast media. AJR Am J Roentgenol. 2001;176:1385-1388.
16. Bettmann MA, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR Contrast Agent Registry. Radiology. 1997;203:611-620.
17. Lasser EC, Lyon SG, Berry CC. Reports on contrast media reactions: analysis of data from reports to the US Food and Drug Administration. Radiology. 1997;203:605-610.
18. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175:621-628.
19. Lang D, Alpern MB, Visintainer PF, Smith ST. Increased risk of anaphylactoid reaction from contrast media in patients on β-adrenergic blockers with asthma. Ann Intern Med. 1991;115:270-276.
20. Rocha M de S. Exacerbation of myasthenia gravis by contrast media [letter]. AJR Am J Roentgenol. 1994;162:997.
21. Mukherjee JJ, Peppercorn DP, Reznek RH, et al. Pheochromocytoma: effect on nonionic contrast medium in CT on circulating catecholamine levels. Radiology. 1997;202:227-231.
22. Macklin D. What's physics got to do with it? A review of the physical principles of fluid administration. J VAD. 1999;4(2):7-11.
23. Vergara M, Seguel S. Adverse reactions to contrast media in CT: effects of temperature and ionic property. Radiology. 1996;199:363-366.
24. Cronin TG. Yawning: an early manifestation of vasovagal reflex. AJR. 1988;150:209.
25. Fishman JE, Aberle DR, Moldawer NP, Belldegrun A, Figlin RA. Atypical contrast reactions associated with systemic interleukin-2 therapy. AJR Am J Roentgenol. 1991;156:833-834.
26. Choyke PL, Miller DL, Lotze MT, Whiteis M, Ebbitt B, Rosenberg SA. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology. 1992;183:111-114.
27. Yoshikawa H. Late adverse reactions to nonionic contrast media. Radiology. 1992;183:737-740.
28. Freed KS, Leder RA, Alexander C, DeLong DM, and Kliewer MA. Breakthrough adverse reactions to low-osmolar contrast media after steroid premedication. AJR Am J Roentgenol. 2001;176:1389-1392.
29. Dehmer GJ, Gresalfi N, Daly D, Oberhardt B, Tate DA. Impairment of fibrinolysis by streptokinase, urokinase, and recombinant tissue-type plasminogen activator in the presence of radiographic contrast agents. J Am Coll Cardiol. 1995;25:1069-1075.
30. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron. 1992;62:413-415.
31. Krause W, Niehues D. Biochemical characterization of x-ray contrast media. Invest Radiol. 1996;31(1):30-42.
32. Fisher HW. Incompatibilities between contrast media and pharmacologic agents. Radiology. 1987;162:875.
33. Irving HD, Burbridge BE. Incompatibility of contrast agents with intravascular medications: work in progress. Radiology. 1989;173:91-92.
34. Mehran R. Radiocontrast-induced acute renal failure: allocations and outcomes. Rev Cardiovasc Med. 2001;2(1):s9-s3.
35. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. J VIR. 2001;12:3-9.
36. Murphy SW, Barrett BJ, Parfrey PS. Contrast neuropathy. J Am Soc Nephrol. 2000;11:177-182.
37. Deray G. Nephrotoxicity of contrast media. Nephrol Dial Transplant. 1999;14:2602-2606.
38. Aspelin P, Aubry P, Fransson, SG, Strasser R, Willenbrock R, Berg KJ, for the NEPHRIC Study Investigators. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-499.
39. Rieger J, Sitter T, Toepfer M, Linsenmaier U, Pfeifer KJ, Schiffl H. Gadolinium as an alternative contrast agent for diagnostic and interventional angiographic procedures in patients with impaired renal function. Nephrol Dial Transplant. 2002;17:824-828.
40. 2 angiography in patients with renal insufficiency. J VIR. 2000;11:35-43.
41. Prince MR, Arnoldus C, Frisoli JK. Nephrotoxicity of high-dose gadolinium compared with iodinated contrast. J Magn Reson Imag. 1996;6(1):162-166.
42. Nyman U, Elmstahl B, Leander P, Nilsson M, Golman K, Almen T. Are gadolinium-based contrast media really safer than iodinated media for digital subtraction angiography in patients with axotemia? Radiology. 2002;223:311-318.
43. Hahn ST, Pfammatter T, Cho KJ. Carbon dioxide gas as a venous contrast agent to guide upper-arm insertion of central venous catheters. Cardiovasc Intervent Radiol. 1995;18(3):146-149.
44. Moresco KP, Patel NH, Namyslowski Y, Shah H, Johnson MS, Trerotola SO. Carbon dioxide angiography of the transplanted kidney: technical considerations and imaging findings. AJR Am J Roentgenol. 1998;171(5):1271-1276.
45. Eschelman DJ, Sullivan KL, Bonn J, Gardiner GA. Carbon dioxide as a contrast agent to guide vascular interventional procedures. AJR Am J Roentgenol. 1998;171(5):1265-1270.
46. 2 versus with iodinated contrast material for inferior vena cava filter placement: a prospective evaluation. Radiology. 2000;216:752-757.
47. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416.
48. Stevens MA, McCollough PA, Tobin KJ, et al. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the PRINCE study: prevention of radiocontrast-induced nephropathy clinical evaluation. J Am Coll Cardiol. 1999;33:403-411.
49. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic contrast media-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343(3):180-184.
50. Tumlin JA. Prophylactic efficacy of fenoldopam in radiocontrast nephropathy: a randomized, double-blind, placebo-controlled trial. J VIR. 2000;11:175.
51. Madyoon K, Croushore L, Weaver D, Mathur V. Use of fenoldopam to prevent radiocontrast nephropathy in high-risk patients. Cathet Cardiovasc Intervent. 2001;53(3):341-345.
52. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer P. Effect of hemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant. 1998;13(2):358-362.
53. Vogt B, Ferrari P, Schonholzer C, et al. Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. Am J Med. 2001;111(9):692-698.
54. Cigarroa RG, Lange RA, Williams RH, Hillis LD. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. Am J Med. 1989;86(6 pt 1):649-652.
55. Rosovsky MA, Rusinek H, Berenstein A, Basak S, Setton A, Nelson PK. High-dose administration of nonionic contrast media: a retrospective review. Radiology. 1996;200:119-122.
56. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology. 1993;188:171-178.
57. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1,620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162(3):329-336.
58. Taylor AJ, Hotchkiss D, Morse RW, McCabe J. PREPARED: preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest. 1998;114(6):1570-1574.
59. Kurnick BRC, Allgren RL, Genter FC, Solomon RJ, Bates ER, Weisberg LS. Prospective study of atrial natriuretic peptide for prevention of radiocontrast-induced nephropathy. Am J Kidney Dis. 1998;31:674-680.
60. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium-channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant. 1989;4(12):1030-1036.
61. Khoury Z, Schlicht JR, Como J, et al. The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy. 1995;15(1):59-65.
62. Erley EM, Duda SH, Rehfuss D, et al. Prevention of radiocontrast media-induced nephropathy in patients with preexisting renal insufficiency by hydration in combination with the adenosine antagonist theophylline. Nephrol Dial Transplant. 1999;14:1146-1149.
63. Katholi RE, Taylor GJ, McCann WP, et al. Nephrotoxicity from contrast media: attenuation with theophylline. Radiology. 1995;195:17-22.
64. Cohen MD, Smith JA. Intravenous use of ionic and nonionic contrast agents in children. Radiology. 1999;191:793-794.